GXR RM (Glucophage® Extended Release Reduced Mass) 500 Milligram (mg) Korea Bioequivalence (BE) Study
Clinical trial NCT04684420 · COMPLETED
Trial details
- NCT number
- NCT04684420
- Sponsor
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-22
- Primary completion
- 2022-03-11
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.